Skip to main content
Veterinary Medicines

HYMATIL 300 mg/ml Solution for injection for cattle

Authorised
  • Tilmicosin

Identifikacija zdravila

Ime zdravila:
HYMATIL 300 mg/ml Solution for injection for cattle
HYMATIL 300 mg/ml SOLUCION INYECTABLE PARA BOVINO Y OVINO
Učinkovina:
Pot uporabe:
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za injiciranje
Withdrawal period by route of administration:
  • Subcutaneous use
    • govedo
      • Meat
        70
        day
    • Sheep
      • Meat
        42
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QJ01FA91
Status dovoljenja:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Opis ovojnine:

Dodatne informacije

Vrsta postopka za pridobitev dovoljenja:
Imetnik dovoljenja za promet z zdravilom:
  • Industrial Veterinaria S.A.
Izdano dovoljenje za promet z zdravilom:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Industrial Veterinaria S.A.
  • Animedica GmbH
Pristojni organ:
  • (AEMPS)
Številka dovoljenja :
  • 2059 ESP
Datum spremembe statusa dovoljenja:
Številka postopka:
  • ES/V/0141/001
Zadevne države članice:

Dokumenti

Povzetek glavnih značilnosti zdravila

Published:
English (PDF)
Download

Navodilo za uporabo

Published:
English (PDF)
Download

Označevanje

Published:
English (PDF)
Download

Povzetek glavnih značilnosti zdravila

Published:
Spanish (PDF)
Download

Označevanje

Published:
Spanish (PDF)
Download

Navodilo za uporabo

Published:
Spanish (PDF)
Download

es-puar-hymatil-300-mg-ml-solution-for-injection-for-cattle-es.pdf

Published:
Spanish (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."